Anesthetic management of a patient with sodium-channel myotonia: a case report [PDF]
Background Sodium-channel myotonia (SCM) is a nondystrophic myotonia, characterized by pure myotonia without muscle weakness or paramyotonia. The prevalence of skeletal muscle channelopathies is approximately 1 in 100,000, and the prevalence of SCM is ...
Naohisa Matsumoto +4 more
doaj +3 more sources
Muscle biopsy and cell cultures: potential diagnostic tools in hereditary skeletal muscle channelopathies [PDF]
Hereditary muscle channelopathies are caused by dominant mutations in the genes encoding for subunits of muscle voltage- gated ion channels. Point mutations on the human skeletal muscle Na+ channel (Nav1.4) give rise to hyperkalemic periodic paralysis ...
G Meola +3 more
doaj +4 more sources
Clinical, electromyographic, and biophysical characterization of the rare Nav1.4 channel mutation SCN4A L1436P [PDF]
IntroductionOur aims were to provide an integrated clinical and biophysical characterization of the rare variant NM_000334.4(SCN4A) c.4307T>C (p.Leu1436Pro; L1436P), affecting the skeletal muscle sodium channel Nav1.4, and to compare its functional ...
François Charles Wang +10 more
doaj +2 more sources
SCN4A-related congenital myopathy in a Han Chinese patient: A case report and literature review [PDF]
SCN4A mutations have been shown to be associated with myotonia, paramyotonia congenita, and periodic paralyses. More recently, loss-of-function variants in the SCN4A gene were also noted to be associated with rarer, autosomal recessive forms of ...
Tina Yee-Ching Chan +5 more
doaj +2 more sources
Phenotypic Variations in Clinical Presentations of Paramyotonia Congenita in Two Brothers [PDF]
Kamalesh Tayade +4 more
doaj +2 more sources
COVID-19 infection and vaccination in patients with skeletal muscle channelopathies. [PDF]
Abstract Introduction/Aims Although we have gained insight into coronavirus disease‐2019 (COVID‐19) caused by severe acute respiratory syndrome–coronavirus 2 since the beginning of the pandemic, our understanding of the consequences for patients with neuromuscular disorders is evolving.
Vivekanandam V, Jayaseelan D, Hanna MG.
europepmc +2 more sources
Novel SCN4A Variants Associated With Myalgic Myotonic Disorder or Paramyotonia. [PDF]
ABSTRACT Background This study aimed to determine the role of five new rare SCN4A variants suspected to cause paramyotonia or myotonic disorder. Methods Ten patients from seven families underwent clinical, neurophysiological, imaging, and muscle biopsy examinations.
Periviita V +6 more
europepmc +2 more sources
Hyperthyroid Hypokalemic Periodic Paralysis in a Nepali Male; A Case Report. [PDF]
ABSTRACT Hyperthyroid Hypokalemic Periodic Paralysis (HHPP), marked by acute weakness and hypokalemia. Prompt potassium replacement and hyperthyroidism management are essential to prevent life‐threatening outcomes. This case highlights its presentation in a Nepali male, reinforcing the need for high clinical suspicion.
Tamang A +6 more
europepmc +2 more sources
Discovery and Treatment of Action Potential-Independent Myotonia in Hyperkalemic Periodic Paralysis. [PDF]
ABSTRACT Objective Hyperkalemic periodic paralysis (hyperKPP) is characterized by attacks of transient weakness. A subset of hyperKPP patients suffers from transient involuntary contraction of muscle (myotonia). The goal of this study was to determine mechanisms causing myotonia in hyperKPP.
Dupont C +4 more
europepmc +2 more sources
Background: Paramyotonia Congenita (PMC) is a rare genetic disorder that affects the sodium ion pump at the level of muscles, retarding muscular relaxation after activation. Symptoms may include isolated or global muscle stiffness, with or without pain.
Morgan Ricks, Warren Lake, Trent Jackman
doaj +1 more source

